This inventor holds 1 USPTO granted patent. Top assignees: Betagene, Inc., The University of Texas System. Active years: 1999.
Company Filing History:
1 out of 4 
1 out of 5,630 
Years Active: 1999
Title: John E Wilson: Innovator in Hexokinase Inhibition
Introduction
John E Wilson is a notable inventor based in East Lansing, MI (US). He has made significant contributions to the field of biochemistry, particularly in the area of hexokinase inhibition. His innovative work has implications for various therapeutic applications.
Latest Patents
Wilson holds a patent for "Methods and compositions for inhibiting hexokinase." This patent discloses compositions and methods aimed at inhibiting hexokinase enzymes in mammalian cells. The invention specifically provides proteins that stimulate the production of trehalose-6-phosphate and their respective genes. It also includes hexokinase-specific ribozymes and genes encoding such constructs. Additionally, the patent describes agents that competitively reduce hexokinase activity, such as inactive hexokinases and fragments that retain mitochondrial binding functions. The patent outlines methods for creating mammalian cells that include these hexokinase inhibitors and various in vitro and in vivo methods for utilizing cells with reduced hexokinase activity.
Career Highlights
Throughout his career, John E Wilson has worked with several prominent organizations. He has been associated with Betagene, Inc. and the University of Texas System. His work in these institutions has allowed him to further his research and contribute to advancements in biochemistry.
Collaborations
Wilson has collaborated with notable colleagues, including He-Ping Han and Thomas C Becker. These collaborations have enriched his research and expanded the impact of his inventions.
Conclusion
John E Wilson's innovative work in inhibiting hexokinase represents a significant advancement in biochemistry. His contributions have the potential to influence therapeutic strategies and improve health outcomes.